|
Status |
Public on Feb 08, 2021 |
Title |
S1PR3–G12-biased agonist ALESIA targets cancer metabolism and promotes glucose starvation |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
Web link |
https://0-www-sciencedirect-com.brum.beds.ac.uk/science/article/pii/S2451945621000040
|
|
|
Citation(s) |
33561428 |
Submission date |
Jan 14, 2020 |
Last update date |
Feb 12, 2021 |
Contact name |
Kei IIDA |
E-mail(s) |
kiida@life.kindai.ac.jp
|
Organization name |
Kindai University
|
Street address |
Kowakae 3-4-1
|
City |
Higashi-Osaka |
State/province |
Osaka |
ZIP/Postal code |
5778502 |
Country |
Japan |
|
|
Platforms (2) |
GPL17303 |
Ion Torrent Proton (Homo sapiens) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (12)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE111352 |
S1PR3–G12-biased agonist ALESIA targets cancer metabolism and promotes glucose starvation [MCF-7 RNA-seq] |
GSE143668 |
S1PR3–G12-biased agonist ALESIA targets cancer metabolism and promotes glucose starvation [HeLa RNA-seq] |
|
Relations |
BioProject |
PRJNA601208 |